Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Nivolumab Monotherapy and Nivolumab Plus Ipilimumab in Recurrent Small Cell Lung Cancer: Results From the CheckMate 032 Randomized Cohort
PaperCitations, authors & open-access status
Nivolumab Monotherapy and Nivolumab Plus Ipilimumab in Recurrent Small Cell Lung Cancer: Results From the CheckMate 032 Randomized Cohort is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 328 citations, 2019 year and hybrid oa status.
328
Citations
2019
Year
hybrid
OA Status